Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript - Thomson StreetEvents

Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript

Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript - Thomson StreetEvents
Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript
Published Oct 28, 2024
14 pages (9506 words) — Published Oct 28, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of EW.N corporate analyst meeting

  
Brief Excerpt:

...All right, everybody. Thanks for your patience. I appreciate it. It's great to see so many people in person and online too. It's an exciting day for Edwards. I'm Mark Wilterding, Head of the Investor Relations department. I'm joined by Sydney and Linda. And like I said, we really appreciate your time here. We've got about 45 minutes for the session today. It will be a combination of some prepared remarks from the panel you see in front of you as well as some time for Q&A. Before we get into it, I'll just call your attention to the forward-looking statement here. please just take a second to familiarize yourself with it. It's also available on our website. And so with that, let me turn it over to our CEO, Bernard Zovighian. Bernard Zovighian ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Edwards Lifesciences Corp
Ticker
EW.N
Time
8:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: David Roman - Goldman Sachs - Analyst : Thank you, Mark. David Roman from Goldman Sachs. You talked a lot about in the presentation today about the impact of this being a randomized controlled study. So each cohort being very well managed. But maybe you could take us into kind of the real-world setting and help us think about how this impacts workflow in the general cardiologists who spends what, eight minutes per patient, maybe as they're going through a visit. So help us think through the patient visit into the general cardiologists to when they show up at a center like yours, for example?

Table Of Contents

Edwards Lifesciences Corp at JPMorgan Healthcare Conference Summary – 2025-01-14 – US$ 54.00 – Edited Brief of EW.N presentation 14-Jan-25 7:15pm GMT

Edwards Lifesciences Corp To Host Annual Investor Conference Summary – 2024-12-04 – US$ 54.00 – Edited Brief of EW.N corporate analyst meeting</ 4-Dec-24 1:30pm GMT

Edwards Lifesciences Corp To Host Annual Investor Conference Transcript – 2024-12-04 – US$ 54.00 – Edited Transcript of EW.N corporate analyst meeting</ 4-Dec-24 1:30pm GMT

Edwards Lifesciences Corp Investor and Analyst TMTT Q&A Session at TCT Summary – 2024-10-30 – US$ 54.00 – Edited Brief of EW.N corporate analyst meeting</ 30-Oct-24 6:00pm GMT

Edwards Lifesciences Corp Investor and Analyst TMTT Q&A Session at TCT Transcript – 2024-10-30 – US$ 54.00 – Edited Transcript of EW.N corporate analyst meeting</ 30-Oct-24 6:00pm GMT

Edwards Lifesciences Corp Q3 2024 Earnings Call Summary – 2024-10-24 – US$ 54.00 – Edited Brief of EW.N earnings conference call or presentation 24-Oct-24 9:30pm GMT

Edwards Lifesciences Corp Q3 2024 Earnings Call Transcript – 2024-10-24 – US$ 54.00 – Edited Transcript of EW.N earnings conference call or presentation 24-Oct-24 9:30pm GMT

Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript – 2024-09-05 – US$ 54.00 – Edited Transcript of EW.N presentation 5-Sep-24 2:15pm GMT

Edwards Lifesciences Corp at Jefferies Heathcare Conference Summary – 2024-06-05 – US$ 54.00 – Edited Brief of EW.N presentation 5-Jun-24 2:30pm GMT

Edwards Lifesciences Corp at Jefferies Heathcare Conference Transcript – 2024-06-05 – US$ 54.00 – Edited Transcript of EW.N presentation 5-Jun-24 2:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript" Oct 28, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Edwards-Lifesciences-Corp-Investor-and-Analyst-TAVR-Q-A-Session-at-TCT-T16157256>
  
APA:
Thomson StreetEvents. (2024). Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript Oct 28, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Edwards-Lifesciences-Corp-Investor-and-Analyst-TAVR-Q-A-Session-at-TCT-T16157256>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.